P852: NEOANTIGENS PREDICTED BY THE GNE NEOANTIGEN PIPELINE IN PATIENTS DIAGNOSED WITH DE NOVO MULTIPLE MYELOMA

P852: NEOANTIGENS PREDICTED BY THE GNE NEOANTIGEN PIPELINE IN PATIENTS DIAGNOSED WITH DE NOVO MULTIPLE MYELOMA

Bibliographic Details
Main Authors:	Y. Jiang, C. Henneges, S. Ruppert, P. Kimes, A. Amitai, A. Qamra, C. Dos Santos, J. N. Paulson, A. Bazeos
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000846292.35223.cf

Similar Items

P1268: DELINEATING THE NEOANTIGEN BURDEN AND TUMOUR MICROENVIRONMENT IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA (DLBCL).
by: Y. Jiang, et al.
Published: (2022-06-01)

Identification and Targeting of Mutant Neoantigens in Multiple Myeloma Treatment
by: Valentina Urzì Brancati, et al.
Published: (2023-04-01)

Lymphoma neoantigens
by: Joshua E. Elias
Published: (2018-06-01)

Inducible de novo expression of neoantigens in tumor cells and mice
by: Damo, Martina, et al.
Published: (2022)

Inducible de novo expression of neoantigens in tumor cells and mice
by: Damo, Martina, et al.
Published: (2021)

PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions
by: Xiaoxiu Tan, et al.
Published: (2023-03-01)

Main Strategies for the Identification of Neoantigens
by: Alexander V. Gopanenko, et al.
Published: (2020-10-01)

Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy
by: Koji Nagaoka, et al.
Published: (2021-12-01)

The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneity
by: Yue Wang, et al.
Published: (2023-12-01)

Seq2Neo: A Comprehensive Pipeline for Cancer Neoantigen Immunogenicity Prediction
by: Kaixuan Diao, et al.
Published: (2022-10-01)

Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions
by: Yanwei Shen, et al.
Published: (2022-08-01)

Molecular mechanism of phosphopeptide neoantigen immunogenicity
by: Yury Patskovsky, et al.
Published: (2023-06-01)

Neoantigens: The Novel Precision Cancer Immunotherapy
by: Tiantian Zhang, et al.
Published: (2023-10-01)

The Value of Microbes in Cancer Neoantigen Immunotherapy
by: Junrui Tian, et al.
Published: (2023-08-01)

Mitochondrial Proteins as Source of Cancer Neoantigens
by: Gennaro Prota, et al.
Published: (2022-02-01)

Neoantigens: promising targets for cancer therapy
by: Na Xie, et al.
Published: (2023-01-01)

434 Concurrent identification of true neoantigens and neoantigen-specific T cells by scRNA-Seq and scTCR-Seq
by: Yukari Kobayashi, et al.
Published: (2023-11-01)

139 Identifying neoantigens in lung adenocarcinoma patients
by: Elizabeth Gensterblum-Miller, et al.
Published: (2023-11-01)

Decoupled neoantigen cross-presentation by dendritic cells limits anti-tumor immunity against tumors with heterogeneous neoantigen expression
by: Kim Bich Nguyen, et al.
Published: (2023-08-01)

Lack of shared neoantigens in prevalent mutations in cancer
by: Concetta Ragone, et al.
Published: (2024-04-01)

Personalised neoantigen‐based therapy in colorectal cancer
by: Ya‐Juan Zhu, et al.
Published: (2023-11-01)

Current Trends in Neoantigen-Based Cancer Vaccines
by: Szu-Ying Ho, et al.
Published: (2023-03-01)

Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy
by: Masahiro Okada, et al.
Published: (2022-02-01)

Neoantigens in cancer immunotherapy: quantity vs. quality
by: Yochai Wolf, et al.
Published: (2023-08-01)

Cancer neoantigens and immunogenicity: mutation position matters
by: Aude-Hélène Capietto, et al.
Published: (2020-05-01)

Neoantigens and their clinical applications in human gastrointestinal cancers
by: Zahra Shokati Eshkiki, et al.
Published: (2022-09-01)

Designing neoantigen cancer vaccines, trials, and outcomes
by: Nupur Biswas, et al.
Published: (2023-02-01)

Neo-intline: integrated pipeline enables neoantigen design through the in-silico presentation of T-cell epitope
by: Bingyu Li, et al.
Published: (2023-10-01)

Structural basis for self-discrimination by neoantigen-specific TCRs
by: John P. Finnigan, et al.
Published: (2024-03-01)

Author Correction: Molecular mechanism of phosphopeptide neoantigen immunogenicity
by: Yury Patskovsky, et al.
Published: (2023-07-01)

900 TBio BFX 4101: a neoantigen prioritization pipeline for selected tumor-infiltrating lymphocyte therapy
by: Quanyuan He, et al.
Published: (2023-11-01)

The role of isoform switching and neoantigen formation in the response to radiation
by: Abdulghani, M
Published: (2023)

Circular RNA as a source of neoantigens for cancer vaccines
by: Yi Ren, et al.
Published: (2024-03-01)

Neoantigen cancer vaccines: a new star on the horizon
by: Xiaoling Li, et al.
Published: (2024-04-01)

Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy
by: Daniel J. Verdon, et al.
Published: (2021-08-01)

Sources of Cancer Neoantigens beyond Single-Nucleotide Variants
by: Aude-Hélène Capietto, et al.
Published: (2022-09-01)

Exploiting Autophagy-Dependent Neoantigen Presentation in Tumor Microenvironment
by: Evangelos Koustas, et al.
Published: (2023-02-01)

3348 Structural Determinants of Neoantigen Immunogenicity for Cancer Therapy
by: Jason Devlin, et al.
Published: (2019-03-01)

1312 Identification and validation of immunogenic clonal neoantigens for personalized therapies
by: Andrew Craig, et al.
Published: (2023-11-01)

Discovery of U2AF1 neoantigens in myeloid neoplasms
by: Marie Bleakley, et al.
Published: (2023-12-01)